BC
The startup develops pharmaceutical technology for tumor immunity that utilizes multi-omics analysis, receptor ligand discovery, and antibody engineering to enhance drug efficacy. This approach enables the identification of novel therapeutic targets, improving precision medicine and treatment outcomes for patients with cancer.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops pharmaceutical technology for tumor immunity that utilizes multi-omics analysis, receptor ligand discovery, and antibody engineering to enhance drug efficacy. This approach enables the identification of novel therapeutic targets, improving precision medicine and treatment outcomes for patients with cancer.